Autism Studies

Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders

Individuals with high-functioning autism (males and females 10-55 years old) will be recruited for a study that will use harmless and non-invasive brain imaging (functional MRI) to investigate how citalopram (also known as Celexa(r)) helps to reduce symptoms of restricted interests and repetitive behaviors.  Read more >>

Ages: 10 - 55 years

Social Cognition and Interaction Training for Adolescents with High Functioning Autism (SCIT-A)

Ages: 17 - 20 years

A Longitudinal MRI Study of Brain Development in Autism

The goal of the current research project is to increase our understanding of normal brain development and how the brain develops in children with autism and developmental delay. This new information will provide clues about how brain development may differ for individuals with autism and related disorders.  Read more >>

Ages: 18 months to 35 months

SOFIA Study

In this study we are trying to determine what the effects of taking Prozac (fluoxetine ODT) are on repetitive behaviors in children diagnosed with an autism spectrum disorder. Cure Autism Now/Autism Speaks have partnered with a pharmaceutical company in order to better determine what effects this medicine has on treating symptoms related to autism. The medicine is a quick dissolving tablet that disappears in seconds once placed on the tongue.  Read more >>

Ages: 5-17 years

Note:  This study has a placebo (control) group. Study medication and treatment will be provided at no cost.

PAIRS

In this study, we are trying to determine what the effects of taking aripirazole are on children and adolescents diagnosed with autism spectrum disorder who have maladaptive behaviors such as hyperactivity, irritability, aggression, or anxiety.  By treating children with aripriprazole, we hope to improve overall functioning for our study participants.  If you think that your child might be eligible for this study or would like more information, please call the ASPIRE research hotline at 1-800-708-0048.  

Ages: 30 months - 17 years

Note:  Study medication and treatment will be provided free of charge

PREVENT: Metformin Mitigation Of Atypical Antipsychotic-Induced Metabolic Dysregulation In Adolescent Youths

The purpose of this study is to determine whether starting metformin in conjunction with a second-generation antipsychotic (SGA) and providing information about healthy eating and activity will prevent or reduce the amount of weight gain and the metabolic changes typically seen with second-generation antipsychotic medication.  Read more >>